华润双鹤(600062.SH)公告称，公司拟投资设立华润双鹤生物医药产业基金(呼和浩特)投资合伙企业(有 限合伙)，基金目标募集规模为5亿元人民币。公司及全资子公司双鹤(北京)生物技术有限公司拟以自有 资金出资不超过8,700万元人民币，占基金总出资额的比例不超过17.40%。该基金旨在优化公司在合成 生物等重点领域的战略布局，通过发挥与呼和浩特市产业发展的协同优势，丰富合成生物领域投资手 段。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Group 1 - Chengdu has launched its first future industry fund with an initial scale of 112 billion yuan, targeting sectors such as humanoid robots, flying cars, and commercial aerospace [2][3] - The fund aims to create a "billion-level fund cluster" by attracting financial and social capital, focusing on early-stage investments in ten future industry areas [2][3] - Shanghai Pudong has introduced a 2 billion yuan artificial intelligence seed fund to accelerate the transformation of AI research and innovation [3][4] Group 2 - Guangxi has established a technology achievement transformation mother fund with a total scale of 2 billion yuan, focusing on supporting technology companies from seed to growth stages [4][6] - Fujian has initiated its first provincial-level biopharmaceutical industry fund with a target scale of 2 billion yuan, emphasizing investments in innovative drugs and medical devices [5][6] - Guangxi's first industrial venture capital mother fund has been registered with a total scale of 5 billion yuan, focusing on technology innovation in the industrial sector [6][7] Group 3 - The Longjiang specialized vehicle investment fund has been established with a total scale of 5 billion yuan, focusing on specialized vehicles and high-end manufacturing [9] - The Shanghai Baoshan AIC fund has been launched with a total scale of 500 million yuan, marking the first AIC equity investment fund in Shanghai [8][9]